Company Information
USD
1.15
- (1.8%)
NASDAQ:KPTI, KARYOPHARM THERAPEUTICS INC.
Industry: Biotechnology
End of Day: 6 May 2024 GMT-4
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma.
The company derives its revenue from United States.
Address
85 Wells Avenue
2nd Floor
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Barry E. Greene
Director
Mr. Chen Schor, M.B.A.
Director
Mr. Garen G. Bohlin
Director
Dr. Deepika Rachel Pakianathan
Director
Mr. Michael Mason, C.P.A.,M.B.A.
CFO/Chief Accounting Officer/Executive VP/Treasurer
Dr. Mansoor Raza Mirza, M.D.
Director
Mr. Richard Paulson, M.B.A.
CEO/Director/President
Ms. Christy J. Oliger
Director
Dr. Reshma Rangwala, M.D.,PhD
Chief Medical Officer/Executive VP
Mr. Michael Mano, J.D.
General Counsel/Secretary/Senior VP
Ms. Sohanya Roshan Cheng, M.B.A.
Executive VP/Other Executive Officer
Mr. Stuart Poulton
Executive VP/Other Executive Officer
Dr. Zhen Su
Director
Ownership
Institution Holdings
BlackRock Inc
10,071,677 (8.753%)
Vanguard Group Inc
8,710,158 (7.570%)
Avidity Partners Management LP
8,298,570 (7.212%)
Palo Alto Investors, LLC
5,102,193 (4.434%)
Palo Alto Investors LP
5,102,193 (4.434%)
Chione Ltd.
4,400,000 (3.824%)
BlackRock Fund Advisors
4,006,012 (3.481%)
Vanguard Investments Australia Ltd
3,209,248 (2.789%)
Citadel Advisors Llc
3,103,888 (2.697%)
Vanguard
3,067,526 (2.666%)
Individual Holdings
Mr. Richard Paulson, M.B.A.
1,160,836 (1.009%)
Mr. Michael Mason, C.P.A.,M.B.A.
398,756 (0.347%)
Ms. Sohanya Roshan Cheng, M.B.A.
393,509 (0.342%)
Dr. Reshma Rangwala, M.D.,PhD
349,720 (0.304%)
Mr. Stuart Poulton
329,511 (0.286%)
Mr. Michael Mano, J.D.
277,852 (0.242%)
Mr. Garen G. Bohlin
45,140 (0.040%)
Mr. Barry E. Greene
13,606 (0.017%)
Funds Holdings
Vanguard US Total Market Shares ETF
3,209,248 (2.789%)
iShares Russell 2000 ETF
2,740,550 (2.382%)
iShares Russell 2000 Growth ETF
983,668 (0.855%)
State Street Russell Small/Mid Cap®
662,524 (0.576%)
Vanguard Russell 2000 Index Fund
366,404 (0.318%)
NT R2000 Index Fund - NL
326,098 (0.283%)
BlackRock Extended Equity Market
310,908 (0.270%)
NT R2000 Index Fund - DC - NL
256,805 (0.223%)
BlackRock - Extended Mkt Fund CF
252,384 (0.219%)
NT Russell 2000 Growth Index Eq Strat
245,074 (0.213%)
Make Smart Investment Choices
8BIT Global Pte Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
